Results 131 to 140 of about 316,749 (274)

Image-based Quantification of 3D Morphology for Bifurcations in the Left Coronary Artery: Application to Stent Design [PDF]

, 2016
Background Improved strategies for stent‐based treatment of coronary artery disease at bifurcations require a greater understanding of artery morphology.
Ellwein, Laura M., Foley, Dennis, LaDisa, John F., Jr., Marks, David S., Migrino, Raymond Q., Sherman, Sara   +5 more
core   +1 more source

Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stent for In‐Stent Restenosis and De‐Novo Lesions: A Meta‐Analysis of Randomized Controlled Trials

Health Science Reports, Volume 9, Issue 5, -Not available-.
ABSTRACT Background and Aims Drug‐coated balloons (DCBs) and drug‐eluting stents (DESs) are commonly used in percutaneous coronary interventions (PCI), but their long‐term comparative effectiveness remains unclear. This meta‐analysis aimed to compare the clinical and angiographic outcomes of DCB versus DES in patients with in‐stent restenosis (ISR) and
Arman Soltani Moghadam, Sina Kazemian, Shayan Shojaei, Saman Soltani Moghadam, Reza Hosseini Dolama, Rasoul Ebrahimi, Fatemeh Ojaghi Shirmard, Seyed Morteza Ali Pourfaraji, Mohammad Sadeq Najafi, Sara Hobaby, Hamidreza Soleimani, Masih Tajdini, Behnam Tehrani, Dhaval Kolte, Islam Elgendy, Sandeep Basavarajaiah, Azeem Latib, Yasar Sattar, M. Chadi Alraies, Kaveh Hosseini   +19 more
wiley   +1 more source

A Rapid and Computationally Inexpensive Method to Virtually Implant Current and Next-Generation Stents into Subject-Specific Computational Fluid Dynamics Models [PDF]

, 2011
Computational modeling is often used to quantify hemodynamic alterations induced by stenting, but frequently uses simplified device or vascular representations.
Feinstein, Jeffrey A., Gundert, Timothy J., Koo, Bon-Kwon, LaDisa, John F., Shadden, Shawn C., Williams, Andrew R.   +5 more
core   +1 more source

Angiotensin-converting enzyme insertion/deletion polymorphism does not influence the restenosis rate after coronary stent implantation [PDF]

, 2002
Background. Experimental studies have shown an activation of the angiotensin-converting enzyme (ACE) system as a response to endothelial injury. Recent publications have elucidated the hypothesis that the ACE gene polymorphism may influence the level of ...
de Jaegere, Peter, Ferrari, Markus, Figulla, Hans R., Grip, Lars, Hausmann, Dirk, Koschyk, Dietmar H., Mudra, Harald, Rieber, Johannes, Rothman, Martin, Schächinger, Volker, Voudris, Vassilis   +10 more
core   +1 more source

Application of underdamped Langevin dynamics simulations for the study of diffusion from a drug-eluting stent

, 2018
We use a one-dimensional two layer model with a semi-permeable membrane to study the diffusion of a therapeutic drug delivered from a drug-eluting stent (DES).
Farago, Oded, Regev, Shaked
core   +1 more source

Recurrent intra-stent coronary restenosis in a carrier of non-disease-specific antinuclear antibodies

European Journal of Case Reports in Internal Medicine
Intracoronary in-stent restenosis (ISR) is a phenomenon that generally occurs between 3 and 6 months after stent placement. With the introduction of drug-eluting stents (DES), the incidence of ISR has decreased but not disappeared.
Benedetta Tomberli, Stefano Fumagalli, Tiziana Cristina Minopoli, Silvia Menale, Valentina Scheggi, Niccolò Marchionni   +5 more
doaj   +1 more source

Assessment of Plaque Characteristics by Contrast-Enhanced Ultrasound and Stent Restenosis following Carotid Artery Stenting: A Retrospective Study

Medicina
Background and objective: carotid artery stenosis contributes significantly to ischemic strokes, with management options including carotid endarterectomy (CEA) and carotid artery stenting (CAS) ischemic stroke risk can be reduced.
Agnė Gimžauskaitė, Donatas Inčiūra, Gintautė Diringytė, Saulius Lukoševičius, Rytis Kaupas, Andrius Pranculis, Aistė Mačiulaitytė, Algidas Basevičius, Milda Kuprytė, Edgaras Stankevičius, Jurgita Plisienė   +10 more
doaj   +1 more source

Restenosis risk factors after coronary stenting in metabolic syndrome patients

Кардиоваскулярная терапия и профилактика, 2007
This review is devoted to coronary restenosis after stent implantation in metabolic syndrome (MS) patients. It is known that some clinical factors increase restenosis risk, first of all, diabetes mellitus.
N. M. Danilov, T. T. Gorgadze, A. P. Savchenko, I. E. Chazova   +3 more
doaj  

Comparative efficacy of drug-eluting balloon and drug-eluting stent for treatment of in-stent restenosis: a systematic review and meta-analysis

Journal of the Pakistan Medical Association
Objective: To compare the efficacy of drug-eluting stents and drug-eluting balloons in treating in-stent restenosis. Method: The systematic review was conducted from January to February 2022, and comprised literature search on PubMed, ProQuest ...
Tinanda Tarigan, Daniel Sukmadja, Kaka Citta Prasiddha, Rizkan Triatmaja   +3 more
doaj   +1 more source

Development of coronary stents using advanced results of materials science and technology [PDF]

, 2004
Stents are high tech endovascular implants. K&M Inc. is the single Eastern European stent producer company. The market needs more biocompatible devices as the trend of the stent development all the producers have to react.
Dobránszky, János, Major, L., Nyitrai, Zs., Puskás, Zs.   +3 more
core